News
Ruling out PE in patients with low C-PTP and D dimer of less than 1,000 ng/mL
April 30, 2021
Can we rule out pulmonary embolism (PE) in patients with a low clinical pretest probability (C-PTP) and a D dimer of less than 1,000 ng/mL?
News
Pediatric bronchiolitis: Less is more
April 27, 2021
With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on supportive care, researchers say.
News
Pneumonia risk soars in heart failure patients, especially HFpEF
April 19, 2021
An analysis of two large trials found that patients with heart failure have an elevated risk of pneumonia and related adverse cardiovascular events.
News
How some COVID-19 vaccines could cause rare blood clots
April 14, 2021
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
News
List of COVID-19 high-risk comorbidities expanded
April 6, 2021
Underlying conditions increase the risk of severe outcomes for patients infected with SARS-CoV-2.
News
New guidelines on antibiotic prescribing focus on shorter courses
April 6, 2021
“Many physicians do not prescribe short-course therapy, frequently defaulting to 10-day courses regardless of the condition.”
News
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
April 2, 2021
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
News
New guidelines on the diagnosis and treatment of adults with CAP
March 30, 2021
What are the most up-to-date, evidence-based recommendations for the diagnosis and treatment of community-acquired pneumonia (CAP)?
News
Pediatric bronchiolitis admissions to ICU fall during COVID-19
March 29, 2021
It’s unlikely that the reduction in bronchiolitis PICU admissions was due to parents not bringing babies to the hospital or infants not getting admitted.
News
Metoprolol increases severity, but not risk, of COPD exacerbations
March 26, 2021
Does metoprolol affect time until exacerbation in patients with moderate to severe chronic obstructive pulmonary disease (COPD) without an alternative indication for beta-blocker use?